Nectar Lifesciences informs about disclosures

07 Mar 2026 Evaluate
Nectar Lifesciences has informed that this is with reference to letter no. NLL/CS/2024- 414 dated October 07, 2024, vide which the Company had informed pending Litigation(s) as required under Regulation 30 of the LODR Regulations. Pursuant to captioned regulations, it has enclosed necessary disclosures in prescribed format for details/ updation of Litigation and/ or orders passed by any regulatory authority or judicial body as per Annexure- 1.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

11.80 -0.08 (-0.67%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×